US Health & Fitness
Regulatory pressure is mounting on Amgen’s inflammatory disorder drug, Tavneos, with the European Medicines Agency recommending revocation of the product’s approval in its territory.…
AbbVie is boosting its already strong presence in immunology with the acquisition of Apogee Therapeutics,…
A simmering dispute between Eli Lilly and the nation’s hospitals boiled over last week. The…
Abarca Health and LucyRx announced last week that they are combining to build an independent…
For decades, employer-sponsored healthcare relied on the same predictable levers to manage spending. Employers rolled…
At a time where vaccine skepticism is growing and the childhood vaccine schedule updated in…
Batten down the digital hatches – a flood of technical vulnerabilities is on the horizon. …
